INFECTION-PERMISSIVE IMMUNIZATION WITH INFLUENZA-VIRUS NEURAMINIDASE PREVENTS WEIGHT-LOSS IN INFECTED MICE

被引:72
作者
JOHANSSON, BE [1 ]
GRAJOWER, B [1 ]
KILBOURNE, ED [1 ]
机构
[1] NEW YORK MED COLL,DEPT MICROBIOL & IMMUNOL,VALHALLA,NY 10595
关键词
VACCINE; PATHOGENESIS; INFLUENZA VACCINE;
D O I
10.1016/0264-410X(93)90130-P
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In studies of infection of young Balb/c mice with a mouse virulent strain of X-31 (H3N2) influenza A virus we have shown a profound virus dose-related effect of infection on body weight. Most of this effect is prevented by prior administration of either inactivated whole virus vaccine, which prevents infection, or purified influenza virus neuraminidase, which is infection-permissive, but reduces pulmonary virus replication by 1.5 to 3 orders of magnitude. These studies support the concept of infection-permissive immunization and suggest that levels of virus replication previously shown to be antigenic can be sustained without significant systemic effects.
引用
收藏
页码:1037 / 1039
页数:3
相关论文
共 6 条
[1]   PROGRAMMED ANTIGENIC-STIMULATION - KINETICS OF THE IMMUNE-RESPONSE TO CHALLENGE INFECTIONS OF MICE PRIMED WITH INFLUENZA INACTIVATED WHOLE VIRUS OR NEURAMINIDASE VACCINE [J].
JOHANSSON, BE ;
KILBOURNE, ED .
VACCINE, 1991, 9 (05) :330-333
[2]   COMPARATIVE LONG-TERM EFFECTS IN A MOUSE MODEL SYSTEM OF INFLUENZA WHOLE VIRUS AND PURIFIED NEURAMINIDASE VACCINES FOLLOWED BY SEQUENTIAL INFECTIONS [J].
JOHANSSON, BE ;
KILBOURNE, ED .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (04) :800-809
[3]   PURIFIED INFLUENZA-VIRUS HEMAGGLUTININ AND NEURAMINIDASE ARE EQUIVALENT IN STIMULATION OF ANTIBODY-RESPONSE BUT INDUCE CONTRASTING TYPES OF IMMUNITY TO INFECTION [J].
JOHANSSON, BE ;
BUCHER, DJ ;
KILBOURNE, ED .
JOURNAL OF VIROLOGY, 1989, 63 (03) :1239-1246
[4]   CORRELATED STUDIES OF A RECOMBINANT INFLUENZA-VIRUS VACCINE .1. DERIVATION AND CHARACTERIZATION OF VIRUS AND VACCINE [J].
KILBOURN.ED ;
SCHULMAN, JL ;
SCHILD, GC ;
SCHLOER, G ;
SWANSON, J ;
BUCHER, D .
JOURNAL OF INFECTIOUS DISEASES, 1971, 124 (05) :449-&
[5]  
KILBOURNE ED, 1991, MED VIROL, V10, P207
[6]  
SCHULMAN JL, 1963, J EXP MED, V119, P257